Dr. Putman is board certified in internal medicine, pediatrics, adult endocrinology and pediatric endocrinology. She sees patients and participates in clinical research in the Divisions of Endocrinology at Boston Children’s Hospital and Massachusetts General Hospital. Her primary research goal is improving the care of children and young adults with chronic diseases to prevent the endocrine complications that may significantly affect their future adult lives. She has developed several research studies focused on improving our understanding and management of cystic fibrosis (CF) related endocrine disorders, including CF related diabetes and CF related bone disease. She is also collaborating with physicians in Orthopaedic Surgery and General Surgery at Boston Children’s Hospital along with engineers at the Wyss Institute for Biologically Inspired Engineering on technology aimed at improving skeletal health in hospitalized infants and children.

For a full list of Dr. Putman’s publications, please see:



Publications powered by Harvard Catalyst Profiles

  1. The effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosis. J Cyst Fibros. 2021 Sep 13. View abstract
  2. Recombinant growth hormone therapy for cystic fibrosis in children and young adults. Cochrane Database Syst Rev. 2021 08 23; 8:CD008901. View abstract
  3. Perceptions of Diabetes Technology Use in Cystic Fibrosis-Related Diabetes Management. Diabetes Technol Ther. 2021 Jul 20. View abstract
  4. The Effects of Ivacaftor on Bone Density and Microarchitecture in Children and Adults with Cystic Fibrosis. J Clin Endocrinol Metab. 2021 03 08; 106(3):e1248-e1261. View abstract
  5. Monogenic Diabetes in a Child with Cystic Fibrosis: A Case Report and Review of the Literature. J Endocr Soc. 2021 Jan 01; 5(1):bvaa165. View abstract
  6. New and Emerging Technologies in Type 1 Diabetes. Endocrinol Metab Clin North Am. 2020 12; 49(4):667-678. View abstract
  7. Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19. Diabetes Care. 2020 12; 43(12):2938-2944. View abstract
  8. Oral ethinyl estradiol treatment in women with cystic fibrosis is associated with lower bone mineral density. J Clin Transl Endocrinol. 2020 Jun; 20:100223. View abstract
  9. Endocrine Complications of Cystic Fibrosis: A Multisystem Disease of the Endocrine Organs. Semin Respir Crit Care Med. 2019 12; 40(6):810-824. View abstract
  10. Cystic fibrosis bone disease: Pathophysiology, assessment and prognostic implications. J Cyst Fibros. 2019 10; 18 Suppl 2:S48-S55. View abstract
  11. Growth failure and treatment in cystic fibrosis. J Cyst Fibros. 2019 10; 18 Suppl 2:S82-S87. View abstract
  12. Cystic fibrosis bone disease treatment: Current knowledge and future directions. J Cyst Fibros. 2019 10; 18 Suppl 2:S56-S65. View abstract
  13. Automated glycemic control with the bionic pancreas in cystic fibrosis-related diabetes: A pilot study. J Cyst Fibros. 2020 01; 19(1):159-161. View abstract
  14. Bone Health Screening Practices Among Neurologists in Patients on Antiepileptic Drugs: A Quality Improvement Project. Pediatr Neurol. 2020 01; 102:49-55. View abstract
  15. Recombinant growth hormone therapy for cystic fibrosis in children and young adults. Cochrane Database Syst Rev. 2018 12 17; 12:CD008901. View abstract
  16. Low bone density and fractures before and after pediatric lung transplantation. Bone. 2018 06; 111:129-134. View abstract
  17. Celiac Disease in Patients with Cystic Fibrosis-Related Bone Disease. Case Rep Endocrinol. 2017; 2017:2652403. View abstract
  18. Differences in Trabecular Microstructure Between Black and White Women Assessed by Individual Trabecular Segmentation Analysis of HR-pQCT Images. J Bone Miner Res. 2017 May; 32(5):1100-1108. View abstract
  19. A pediatric animal model to evaluate the effects of disuse on musculoskeletal growth and development. J Biomech. 2016 10 03; 49(14):3549-3554. View abstract
  20. Young adults with cystic fibrosis have altered trabecular microstructure by ITS-based morphological analysis. Osteoporos Int. 2016 08; 27(8):2497-505. View abstract
  21. Body composition, lung function, and prevalent and progressive bone deficits among adults with cystic fibrosis. Joint Bone Spine. 2016 Mar; 83(2):207-11. View abstract
  22. High incidence of fracture events in patients with Long-Gap Esophageal Atresia (LGEA): A retrospective review prompting implementation of standardized protocol. Bone Rep. 2015 Dec; 3:1-4. View abstract
  23. Trends in bone mineral density in young adults with cystic fibrosis over a 15 year period. J Cyst Fibros. 2015 Jul; 14(4):526-32. View abstract
  24. Two-year changes in bone density after Roux-en-Y gastric bypass surgery. J Clin Endocrinol Metab. 2015 Apr; 100(4):1452-9. View abstract
  25. Response letter to the editor. J Clin Endocrinol Metab. 2015 Jan; 100(1):L9-L10. View abstract
  26. Defects in cortical microarchitecture among African-American women with type 2 diabetes. Osteoporos Int. 2015 Feb; 26(2):673-9. View abstract
  27. Compromised bone microarchitecture and estimated bone strength in young adults with cystic fibrosis. J Clin Endocrinol Metab. 2014 Sep; 99(9):3399-407. View abstract
  28. Differences in skeletal microarchitecture and strength in African-American and white women. J Bone Miner Res. 2013 Oct; 28(10):2177-85. View abstract
  29. 50 years ago in the Journal of Pediatrics: Neonatal fibrous dysplasia. Turner AF, Mikity VG, Meyers HI. J Pediatr 1963;62:936-7. J Pediatr. 2013 Jun; 162(6):1119. View abstract
  30. Measures of the forearm via a portable device: ready for prime time? J Clin Densitom. 2013 Jan-Mar; 16(1):125-6. View abstract
  31. A randomized clinical trial of vitamin D supplementation in healthy adolescents. J Adolesc Health. 2013 May; 52(5):592-8. View abstract
  32. Cortical microstructure and estimated bone strength in young amenorrheic athletes, eumenorrheic athletes and non-athletes. Bone. 2012 Oct; 51(4):680-7. View abstract
  33. Contribution of villous atrophy to reduced intestinal maltase in infants with malnutrition. J Pediatr Gastroenterol Nutr. 2000 May; 30(5):494-502. View abstract
  34. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab. 1998 Dec; 83(12):4474-80. View abstract
  35. Effects of malnutrition on expression and activity of lactase in children. Gastroenterology. 1997 Mar; 112(3):742-51. View abstract
  36. Developmental changes in lactase-phlorizin hydrolase precursor isoforms in the rat. J Pediatr Gastroenterol Nutr. 1992 Oct; 15(3):260-9. View abstract
  37. Mosaic expression of brush-border enzymes in infants with chronic diarrhea and malnutrition. J Pediatr Gastroenterol Nutr. 1992 May; 14(4):371-9. View abstract